منبع: MarketBeat
خبرگزاری
سهام
اهمیت متوسط
Maravai LifeSciences Q2 Earnings Call Highlights
Maravai LifeSciences NASDAQ: MRVI reported second-quarter 2026 revenue growth and a sharp improvement in adjusted profitability, while maintaining its full-year revenue outlook and raising its adjusted EBITDA forecast.
نمادهای مرتبط
1
M
MRVI
MRVI
منبع: MarketBeat
مشاهده منبع